UBS Group’s Allergan plc. AGN.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,508
| Closed | -$884K | – | 7317 |
|
|
2017
Q4 | $884K | Buy |
1,508
+652
| +76% | +$382K | ﹤0.01% | 3099 |
|
|
2017
Q3 | $632K | Sell |
856
-960
| -53% | -$709K | ﹤0.01% | 3298 |
|
|
2017
Q2 | $1.58M | Buy |
1,816
+849
| +88% | +$736K | ﹤0.01% | 2581 |
|
|
2017
Q1 | $820K | Buy |
967
+212
| +28% | +$180K | ﹤0.01% | 2975 |
|
|
2016
Q4 | $576K | Buy |
755
+60
| +9% | +$45.8K | ﹤0.01% | 3218 |
|
|
2016
Q3 | $571K | Buy |
695
+56
| +9% | +$46K | ﹤0.01% | 3082 |
|
|
2016
Q2 | $533K | Buy |
639
+597
| +1,421% | +$498K | ﹤0.01% | 3105 |
|
|
2016
Q1 | $39K | Sell |
42
-422
| -91% | -$392K | ﹤0.01% | 4894 |
|
|
2015
Q4 | $477K | Buy |
464
+422
| +1,005% | +$434K | ﹤0.01% | 3184 |
|
|
2015
Q3 | $40K | Buy |
+42
| New | +$40K | ﹤0.01% | 4886 |
|